ArticleTransgender health2025
Outcomes of Combining Mastectomy and Hysterectomy for Transmasculine Patients.
Article in Transgender health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Many transmasculine patients undergo gender-affirming mastectomy and hysterectomy. Conflicting evidence exists whether these procedures may be safely combined. The purpose of this study is to compare post-operative complications between transmasculine patients who underwent mastectomy alone versus mastectomy in combination with hysterectomy. Methods: Retrospective chart review was performed on patients who underwent mastectomy between January 2020 and September 2022 ( Results: Overall rate of chest wall complications was 8.8%. Combination of mastectomy with hysterectomy within the same day significantly increased operation time (311 vs. 166 min, Conclusion: Combining mastectomy and hysterectomy is not a benign undertaking as it is associated with increased risk of post-operative chest wall infection. Multidisciplinary surgical teams treating transmasculine patients should choose a surgical plan that optimizes patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.